Future studies including PET amyloid and tau assessment of AD pathology as well as longer follow-up are warranted to define better the role of cerebrovascular mechanisms in the prediction of cognitive deterioration in asymptomatic elderly individuals. This evidence concerns the gene MAPT and Alzheimer disease.